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Abstract
Background: The dual-luciferase assay has been widely used in cell lines to determine rapidly but
accurately the activity of a given promoter. Although this strategy has proved very useful, it does
not allow the promoter and gene function to be analyzed in the context of the whole organism.
Results:  Here, we present a rapid and sensitive assay based on the classical dual-luciferase
reporter technique which can be used as a new tool to characterize the minimum promoter region
of a gene as well as the in vivo response of inducible promoters to different stimuli. We illustrate
the usefulness of this system for studying both constitutive (telomerase) and inducible (NF-κB-
dependent) promoters. The flexibility of this assay is demonstrated by induction of the NF-κB-
dependent promoters using simultaneous microinjection of different pathogen-associated
molecular patterns as well as with the use of morpholino-gene mediated knockdown.
Conclusion: This assay has several advantages compared with the classical in vitro (cell lines) and
in vivo (transgenic mice) approaches. Among others, the assay allows a rapid and quantitative
measurement of the effects of particular genes or drugs in a given promoter in the context of a
whole organism and it can also be used in high throughput screening experiments.
Background
The zebrafish has been established as an excellent model
for studying any biological process. This organism pos-
sesses many advantages including ease of experimenta-
tion, optical clarity, drug administration, amenability to
in vivo manipulation and feasibility of reverse and forward
genetic approaches. The fish reach sexual maturity in only
3 to 4 months, and adult females are capable of producing
100 to 200 eggs weekly. Many thousands of animals can
be kept in a fish facility requiring much less space than
mice or other mammals, and hence the zebrafish is
regarded as a cost-effective experimental vertebrate model
for large-scale genetic screening [1]. Furthermore, the high
degree of homology between the zebrafish genome and
that of humans makes such discoveries especially perti-
nent to human disease and development [2,3].
Morpholino antisense oligonucleotides (MO) have been
widely used to inhibit gene function in zebrafish embryos
[4-7] and are usually used as sequence-specific transla-
tion-blocking or splicing-blocking agents. Recently, a
quantitative assessment of the knockdown efficiency of
morpholinos has been performed in zebrafish embryos
and its effectiveness proved [8]. Furthermore, microinjec-
tion of DNA constructs into single-cell fertilized zebrafish
embryos has also proven successful in the generation of
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transgenic zebrafish. The widespread use of fluorescent
proteins in mammalian systems has been successfully
adapted for use in zebrafish, which are well-suited to the
use of fluorescence because of their optical clarity and
external development. By linking a fluorescent protein
such as enhanced green fluorescent protein (eGFP) or Dis-
cosoma sp. red fluorescent protein (DsRed) to a gene or
promoter of interest, expression can be easily visualized in
living animals [9].
The dual luciferase assay has been widely used in cell lines
to determine rapidly and accurately the activity of a given
promoter. Although this strategy has been very useful, it
does not allow analysis of the promoter and gene function
in the context of the whole organism. To overcome these
limitations, we have developed a protocol based on the
dual luciferase system in zebrafish embryos. We illustrate
the usefulness of this system for studying the promoter of
telomerase, a key enzyme in the fields of cancer, stem cells
and aging [10], and a NF-κB-dependent promoter, a mas-
ter regulator of the immune response [11]. The luciferase
reporter DNA plasmids were injected into zebrafish
embryos at the one-cell developmental stage, together
with MO or the expression constructs of interest, and the
luciferase activity was determined in the time frame of
MO activity (24–48 h later). In addition, the flexibility of
this assay is also illustrated by activation of the NF-κB-
dependent promoters by simultaneous microinjection of
different pathogen-associated molecular patterns
(PAMPs).
The protocol presented here provides details of how to
apply the dual-luciferase assay to determining the activity
of constitutive and inducible promoters in zebrafish
embryos. This approach involves three steps: (1) cloning
the promoter of interest in the firefly luciferase reporter
construct, (2) microinjecting the embryos with this con-
struct together with the appropriate Renilla  luciferase
reporter and (3) measuring the promoter activity with the
dual luciferase system in whole embryo extracts.
Results
The protocol presented here should result in very sensitive
and accurate measurement of promoter activity and anal-
ysis of gene function in the context of the whole organism,
which represents an important advantage over traditional
measurement in cell lines. We first illustrated the useful-
ness of our protocol to analyze the promoter activity of
zebrafish telomerase-reverse transcriptase (zfTERT) (Fig.
1). At 24 h post-injection (hpi), the 3 Kb fragment
upstream of the zfTERT coding sequence was able to drive
the expression of the firefly luciferase reporter while the 1
Kb fragment failed to significantly increased the basal
expression. Therefore, the relative promoter activity of
each fragment could be quantitatively determined.
Analysis of zfTERT promoter activity in whole zebrafish embryos Figure 1
Analysis of zfTERT promoter activity in whole zebrafish embryos. Zebrafish one to eight-cell embryos were microin-
jected with plessEGFPLuc, zfpTERT(1 Kb)-EGFPLuc or zfpTERT(3 Kb)-EGFPLuc and the pRL-CMV (10:1) reporter vectors. 
Twenty-four hours after microinjection, the firefly and Renilla luciferase activity was measured using the Dual-Luciferase 
Reporter Assay System. The results are expressed as the mean ± S.E. of normalized luciferase activity relative to plessEGFPLuc 
injected embryos. *p < 0.05 vs. plessEGFPLuc. †p < 0.05 vs. zfpTERT(1 Kb)-EGFPLuc.BMC Biotechnology 2008, 8:81 http://www.biomedcentral.com/1472-6750/8/81
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The critical step in the protocol presented here is the cor-
rect choice of the promoter used for normalization. The
cytomegalovirus (CMV) immediate-early promoter is a
strong promoter used for both the in vitro and in vivo
expression of proteins in signal transduction and gene
therapy studies. However, CMV activity is induced by
external stimuli such as endotoxin from Gram-negative
bacteria (lipopolysaccharide, LPS), cytokines and phorbol
esters [12]. Therefore, for the study of NF-κB activation,
we first have studied the effects of bacterial LPS and DNA
in the expression of several Renilla luciferase reporter con-
structs. Among the four candidates tested, the CMV pro-
moter was strongly induced by both PAMPs, i.e.
Escherichia coli LPS (EcLPS) and Vibrio anguillarum DNA
(VaDNA), whereas the translation elongation factor EF1α
promoter was inhibited by EcLPS and, to some extent, by
VaDNA. In contrast, the herpes simplex virus thymidine
kinase (TK) promoter and the early SV40 enhancer/pro-
moter region showed a more constant expression (Fig. 2A
and 2B) and were therefore selected for further studies.
Figure 2C illustrates the profound effects of the plasmid
used for normalization in the measurement of the induc-
tion of NF-κB. When using EcLPS, a 29 vs. 14 fold induc-
tion of NF-κB activity was obtained with the TK and the
CMV promoters, respectively (Fig. 2C), indicating that
induction of CMV by EcLPS resulted in the underestima-
tion of the NF-κB activation by this PAMP. Similarly, 21
vs. 738 fold induction of NF-κB was observed with
VaDNA when using the SV40 and the TK promoters,
respectively (Fig. 2C), indicating that the inhibition of the
TK promoter by VaDNA resulted in the overestimation of
the NF-κB induced by this PAMP.
We finally validated the usefulness of this technique for
studying a gene of interest by using MO-gene mediated
knockdown. Figure 3 illustrates an example of the inhibi-
tion of the NF-κB activation triggered by VaDNA using a
translation-blocking MO against MyD88 [13], an adaptor
protein involved in the downstream signalling following
the engagement of bacterial DNA by its cognate receptor
(TLR9) [14]. The results showed that injection of the MO
against MyD88 resulted in a significant inhibition (>
30%) of the NF-κB activation induced by bacterial DNA,
while injection of a MO directed against TLR3, which is
involved in the recognition of double-stranded RNA [15],
failed to affect the NF-κB activation induced by bacterial
DNA (Fig. 3).
Discussion
The protocol presented here provides details of how to
apply the dual-luciferase assay to determining the activity
of both constitutive and inducible promoters in zebrafish
embryos. Beyond genetics and experimental tools, the
strength of the zebrafish resides in the analysis of pheno-
type [1]. Perhaps no other organism (and certainly no ver-
tebrate) is better suited to high-throughput phenotyping.
The scale that can be achieved in zebrafish experiments is
impressive by vertebrate standards. Early zebrafish
embryos are less than 1 mm in diameter, allowing several
embryos to fit easily in a single well of a 384-well plate.
Whole organisms offer several advantages over cell lines
for forward chemical genetic screens, providing informa-
tion on tissue specificity, toxicity and accounting for bio-
availability. Furthermore, cells are not transformed and
are in their normal physiological milieu of cell-cell and
cell-extracellular matrix interactions [16-18]. Use of the
whole organism can also allow the screening of processes
that are not easily replicated in vitro such as organ devel-
opment. The advantages of zebrafish screening over inver-
tebrate model organisms are their closer evolutionary
relationship to humans [16-18]. Therefore, the assay
described here represents a promising route to the identi-
fication and validation of novel drug targets. Analysis of
the promoter of newly identified genes that underlie
zebrafish disease phenotypes might lead directly to the
identification of novel drug targets or genes that can cor-
rect the phenotype.
Because zebrafish development occurs ex uterus and they
have a large number of offspring, hundreds or thousands
of embryos can be injected per day and the results of this
assay can be obtained within 24–48 h, although shorter
time points can also be analyzed if either the mRNA cod-
ing for the gene under study or the recombinant protein
are used. Although some variation was found between
replicates, these can be easily avoided by the high number
of technical replicates achievable. The high-fold induction
of luciferase activity, together with barely detectable levels
of basal expression, makes it an ideal system for the in vivo
analysis of inducible promoters. In addition, the assay can
be combined with powerful MO-gene mediated knock-
down or gene over-expression to rapidly determine the
functions of a particular gene (1–2 days compared with
months-years needed for the generation of knockout
mice). Therefore, this technique appears to be suitable for
studying the activity and responses of different promoters
and gene functions as well as for the validation of genetic
constructs. However, this technique does not provide spa-
tial information on gene expression and, therefore, it
might be useful as a complementary technique to in situ
hybridization and fluorescent microscopy. To avoid this
limitation, all our promoters drive the expression of a
fusion of eGFP and firefly luciferase, which might allow
the simultaneous determination of the expression levels
and the spatial localization of the promoter under analy-
sis.
A shortcoming of the present assay, however, is the tran-
sient expression of the constructs and, therefore, only
short-term responses of promoters can be studied. ForBMC Biotechnology 2008, 8:81 http://www.biomedcentral.com/1472-6750/8/81
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Optimization of the different Renilla luciferase reporter constructs Figure 2
Optimization of the different Renilla luciferase reporter constructs. Zebrafish one to eight-cell embryos were micro-
injected with 30 ng EcLPS (A, C) or 6.5 ng VaDNA (B, C) and NF-κB::Luc together with the pRL-CMV, pRL-TK, pRL-SV40 or 
pRL-EF1α (10:1) reporter vectors. Twenty-four hours after microinjection, the firefly and Renilla luciferase activity was meas-
ured using the Dual-Luciferase Reporter Assay System. The results are presented as the Renilla luciferase activity (A, B) or as 
the normalized luciferase activity (firefly/Renilla) (C). Each bar represents the mean ± S.E. of ten replicate samples and the data 
are representative of three independent experiments. The asterisk denotes statistically significant differences between the indi-
cated samples.BMC Biotechnology 2008, 8:81 http://www.biomedcentral.com/1472-6750/8/81
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example, the adaptive immune response can not be stud-
ied with the assay since it develops after several weeks. On
the other hand, we have found that normalization is abso-
lutely required for the elimination of experimental varia-
tions. As we have found that the Renilla luciferase plasmid
used for normalization can be induced by external stim-
uli, the choice of the normalization plasmid is critical.
Thus, the CMV immediate-early promoter, which is com-
monly used for normalization in both in vitro and in vivo
studies, is significantly induced by external stimuli such as
endotoxin (LPS) and genomic DNA from bacteria, as pre-
viously reported in cell lines with LPS, cytokines and
phorbol esters [12]. However, this limitation could be eas-
ily overcome using other commercial Renilla  luciferase
reporter vectors, such as those driven by the herpes sim-
plex virus TK promoter (pRL-TK) or the early SV40
enhancer/promoter region (pRL-SV40).
Conclusion
We have developed a rapid and sensitive assay based on
the classical dual-luciferase reporter technique which can
be used as a new tool to characterize the minimum pro-
moter region of a gene and the in vivo response of induci-
ble promoters to different stimuli as well as in high
throughput screening experiments. The flexibility of this
assay is demonstrated by induction of the NF-κB-depend-
ent promoters using simultaneous microinjection of dif-
ferent PAMPs as well as with the use of MO-gene mediated
knockdown.
Methods
Reagents
￿ Firefly (Photinus pyralis) luciferase reporter plasmids
(Table 1).
￿ Sea pansy (Renilla reniformis) reporter plasmids from
Promega: pRL-CMV (Cat.# E2261), pRL-TK (Cat.# E2241)
and/or pRL-SV40 (Cat.# E2231) (Table 1).
￿ Adult zebrafish.
￿ Egg water (60 mg/l Ocean Salt, 0.45 mM NaHCO3,
0.0375 mM CaCO3, 0.05% Methylene Blue)
An example of the usefulness of MO-gene mediated knockdown in combination with the dual-luciferase assay for the analysis  of the NF-κB signaling pathway Figure 3
An example of the usefulness of MO-gene mediated knockdown in combination with the dual-luciferase assay 
for the analysis of the NF-κB signaling pathway. Zebrafish one to eight-cell embryos were microinjected with 6.5 ng 
VaDNA together with the firefly and Renilla reporter vectors as indicated in Legend to Figure 2 alone or in combination with 4 
ng of the indicated morpholinos. Twenty-four hours after microinjection, activation of the NF-κB activation was measured 
using the Dual-Luciferase Reporter Assay System. The results are expressed as normalized luciferase activity relative to con-
trol embryos not injected with MOs. Each bar represents the mean ± S.E. of ten replicate samples and the data are represent-
ative of three independent experiments. The asterisk denotes statistically significant differences between the indicated samples.BMC Biotechnology 2008, 8:81 http://www.biomedcentral.com/1472-6750/8/81
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￿ Agarose-modified Petri dish as described in the
Zebrafish book http://zfin.org/zf_info/zfbook/chapt5/
5.8.html.
￿ Phenol Red Solution (0.5% in PBS, Sigma-Aldrich).
￿ Buffer Tango 10× (Fermentas).
￿ Morpholinos 1 mM stock solution in distilled water
(Gene Tools, LLC).
 MO-Myd88: 5'-TAGCAAAACCTCTGTTATCCAGCGA-3'
[13]
 MO-TLR3: 5'-GTAAAAACATACCTTTAAGAGAGAG-3'
￿ EcLPS: LPS from Escherichia coli strains 0111:B4 (Cat.#
L4391) or 055:B5 (Cat.# L6529) from Sigma-Aldrich.
￿ LPS from E. coli strains 0111:B4 conjugated with FITC
(Cat.# F3625).
￿  VaDNA: phenol-extracted genomic DNA from Vibrio
anguillarum.
￿ Dual-Luciferase Reporter Assay System (Promega, Cat.#
E1910).
￿ Phosphate-buffered saline (PBS).
Equipment
￿ Air incubator set at 28.5°C (Memmert).
￿ Curved-tip forceps.
￿ Straight-tip forceps.
￿ Puller (PC-10, Narishige).
￿ Glass Capillaries with filament (GD-1, Narishige).
￿ Microloader tips (0.5–10 μl, Eppendorf).
￿ Microinjector (IM300, Narishige).
￿ Stereomicroscope (MZ6, Leica).
￿ Pellet pestle, disposable (Sigma-Aldrich): Cordless
motor (Cat.# Z359971) and blue polypropylene (autocl-
avable) (Cat.# Z359947).
￿ Luminometer Optocomp I (MGM Instruments).
￿ Epifluorescence Lumar V12 stereomicroscope equipped
with a digital camera (AxioCam MRm) (Zeiss).
Table 1: Reporter plasmids used in this study
Plasmid name Purpose Relevant features
pEGFPLuc Positive control for assaying the effectiveness 
of transfection
Kanamycin/neomycin marker. This reporter plasmid encodes 
a fusion of eGFP and luciferase from the firefly Photinus pyralis 
driven by the human CMV immediate early promoter 
(Clontech, Cat.# 6169-1).
plessEGFPLuc Negative control Kanamycin/neomycin marker. This vector was created by 
removing the CMV promoter of pEGFPLuc with the 
restriction enzymes AseI and NheI, followed by blunting of 
5'-cohesive ends and autoligation.
zfpTERT(1/3 Kb)-EGFPLuc Determination of the zfTERT promoter activity Kanamycin marker. This vector was created by replacing the 
CMV promoter of pEGFPLuc with a 1 or 3 Kb-fragment of 
the zebrafish telomerase promoter region.
pNF-κB::Luc Assessment of NF-κB activation Ampicillin marker. This vector carries a the cDNA encoding 
the firefly (P. pyralis) luciferase gene placed under the control 
of three synthetic copies of the κB consensus of the 
immunoglobulin κ-chain promoter cloned in the BamHI site 
located upstream of the conalbumin transcription start site 
[19].
pRL-CMV, pRL-TK and pRL-SV40 Normalization Ampicillin marker. The pRL vectors contain the cDNA 
encoding Renilla luciferase cloned from the anthozoan 
coelenterate Renilla reniformis (sea pansy). Three different 
promoter configurations are available; CMV, TK and SV40.
pRL-EF1α Normalization Ampicillin marker. This vector was obtained by inserting the 
EF1α promoter in the pRL-null vector (Promega, Cat. # 
E2271).
Note: pEGFPLuc has been discontinued and is no longer available from Clontech; it can be obtained from the authors on request. Full sequences and 
maps can be found on the Clontech and Promega websites.BMC Biotechnology 2008, 8:81 http://www.biomedcentral.com/1472-6750/8/81
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Procedure
Microinjection
1- Prepare the microinjection mix containing 20 ng/μl of
firefly luciferase and 2 ng/μl Renilla  reporter plasmids.
Add Buffer Tango 10× to a final concentration of 0.5×, and
phenol red solution to a final concentration of 0.05%.
When injecting morpholinos, they should be prepared to
a final concentration of 1–10 μM.
CAUTION! When microinjecting exogenous molecules,
such as PAMPs or drugs, check different Renilla reporter
plasmids and select those with consistent expression.
2- Immediately after spawning, collect fertilized egg with
a Pasteur pipette and place them in egg water on an agar-
ose-modified Petri dish be means of the forceps.
CRITICAL STEP It is very important to microinject the
zebrafish embryos at early developmental stages (from
one- to eight-cells) to ensure that the cytoplasmic flows
introduce DNA into the cell (Fig. 4)
3- Load glass capillaries with 1–5 μl of microinjection mix
by using a 0.5–10-μl microloader tip.
4- Put the Petri dish with the fertilized eggs under a stere-
omicroscope at 40× magnifications and place the loaded
needle toward the yolk sac, close to the embryo cell. By
using the microinjector, insert the tip of the needle into
the yolk and inject a 4 nl drop by setting the proper pres-
sure (50–60 Psi) and time (10–100 ms).
5- Incubate the injected embryos for 24–48 h at 28.5°C in
egg water.
Molecules microinjected in the yolk sac are rapidly delivered into the embryo Figure 4
Molecules microinjected in the yolk sac are rapidly delivered into the embryo. (A) Schematic representation of the 
site of injection in one-cell zebrafish embryo. (B) Visualization of FITC labelled EcLPS upon microinjection into the yolk sac. 
Embryos were microinjected with 3.5 ng LPS from E. coli strains 0111:B4 conjugated with FITC and examined at the indicated 
times with a LUMAR stereomicroscope. hpi, hours post-injection.Publish with BioMed Central    and   every 
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Quantitative evaluation of the response with the Dual-Luciferase 
Reporter Assay System
6- The next day, collect live injected embryos and put
three of them in a 1.5 ml microcentrifuge tube.
7- Remove the egg water, wash the embryos with PBS and
remove it completely.
CAUTION! Take care during the wash because the eggs
may break.
8- Incubate the embryos with 50 μl of passive lysis buffer
(PLB) 1× for 30 min at room temperature, shaking at 150
rpm.
9- After incubation, homogenize the embryos with the
pellet pestle.
CRITICAL STEP From this point onwards, protect sam-
ples from light.
10- Spin the embryo extracts for 3 min at 13,000 rpm to
remove cellular debris.
11- Measure firefly and Renilla luciferase activities accord-
ing to the manufacturer.
￿ Timing
￿ Step 1: 30 min. Preparation of microinjection mix.
￿ Step 2: 10 min. Preparation for injection of 100
zebrafish embryos.
￿ Steps 3–5: 15 min. Microinjection of 100 zebrafish
embryos.
￿ Steps 6–11: 2 h. Quantitative evaluation of the response
of 100 zebrafish embryos with the Dual-Luciferase
Reporter Assay System.
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